Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Hold Tyman (TYMN) by Jefferies
- Buy Shell (SHEL) by DZ Bank
- Sector Perform SIG (SHI) by RBC Capital
- Buy Sainsbury (J) (SBRY) by Tom Winnifrith in ShareProphets
- Avoid Altitude Group (ALT) by Steve Moore in ShareProphets
- Buy Smith & Nephew (SN.) by Berenberg
- Buy Endeavour Mining (EDV) by Berenberg
- Buy Smiths News (SNWS) by Canaccord Genuity
- Buy Kitwave Group (KITW) by Canaccord Genuity
- Speculative Buy Kinovo (KINO) by Canaccord Genuity
- Overweight Standard Chartered (STAN) by JP Morgan
- Neutral Learning Technologies Group (LTG) by Citi
- Avoid Dianomi (DNM) by Steve Moore in ShareProphets
- Strong Buy NATWEST GROUP (NWG) by Charlie Keough in The Motley Fool
- Buy Scottish Mortgage Inv Trust (SMT) by Charlie Keough in The Motley Fool
- Avoid Cambridge Cognition Holdings (COG) by Steve Moore in ShareProphets
- Avoid Abrdn (ABDN) by Edward Sheldon in The Motley Fool
- Avoid ASOS (ASC) by Edward Sheldon in The Motley Fool
- Avoid Kingfisher (KGF) by Edward Sheldon in The Motley Fool
- Buy Barclays (BARC) by Charlie Keough in The Motley Fool
Faron Pharmaceuticals Oy (DI) (FARN) Share Price
Health Care Sector
NOTE: This is based on 3 open tips for Faron Pharmaceuticals Oy (DI) (FARN)
| Latest Bid : 140.00p | Latest Ask : 160.00p |
| High Today : 154.00p | Low Today : 145.00p |
| This Years High : 350.00p | This Years Low : 117.50p |
| Volume : 4,213 | MKT Cap : £108M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Faron Pharmaceuticals Oy (DI) (FARN) Overview
We are a clinical stage biopharmaceutical company focused on building the future of immunotherapy by harnessing the power of the immune system in order to tackle cancer and inflammation. Since our founding in 2007, our goal has been to develop a diverse and unique pipeline rooted in high quality science and innovation. Faron is focused on mastering immune modulation by harnessing endothelial receptors to control and mediate immune responses.Faron Pharmaceuticals Oy (DI) (FARN) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Under Review | Panmure Gordon | Premium Only | 2020-02-07 09:15:00 07/02/2020 | – |
| Buy | Panmure Gordon | Premium Only | 2017-09-07 08:30:00 07/09/2017 | 0.69% |
| Buy | Panmure Gordon | Premium Only | 2017-02-20 14:40:00 20/02/2017 | -37.67% |
Faron Pharmaceuticals Oy (DI) (FARN) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 140.00p | Latest Ask : 160.00p |
| High Today : 154.00p | Low Today : 145.00p |
| This Years High : 350.00p | This Years Low : 117.50p |
| Volume : 4,213 | MKT Cap : £108M |
Faron Pharmaceuticals Oy (DI) Overview
We are a clinical stage biopharmaceutical company focused on building the future of immunotherapy by harnessing the power of the immune system in order to tackle cancer and inflammation. Since our founding in 2007, our goal has been to develop a diverse and unique pipeline rooted in high quality science and innovation. Faron is focused on mastering immune modulation by harnessing endothelial receptors to control and mediate immune responses.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Faron Pharmaceuticals Oy (DI) Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Under Review | Panmure Gordon | Premium Only | 2020-02-07 09:15:00 07/02/2020 | – |
| Buy | Panmure Gordon | Premium Only | 2017-09-07 08:30:00 07/09/2017 | 0.69% |
| Buy | Panmure Gordon | Premium Only | 2017-02-20 14:40:00 20/02/2017 | -37.67% |